CLINAM – Introduction

Posted on by

The European Summit for Clinical Nanomedicine and Targeted Medicine - The Translation to Knowledge Based Nanomedicine

Eighth Conference And Exhibition, June 28 - July 1, 2015

Sunday, June 28, 2015 General Assembly of the European Society for Nanomedicine (15.30 h) Meeting of the International Society for Nanomedicine (16.30 h) Editorial Board Meeting, European Journal of Nanomedicine (18.00 h) Welcome Dinner for Speakers & invited Guests [19.45 Swisstel Le Plaza, 1st Floor]

Co-founded by the Swiss Confederation. Swiss Derpartment of Economic Affairs, Education and Research

Scientific Committee: Prof. Dr. med. Patrick Hunziker, University Hospital Basel (CH) (Chairman) Prof. Dr. Yechezkel Barenholz, Hebrew University, Hadassah Medical School, Jerusalem (IL) Dr. med. h.c. Beat Lffler, MA, European Foundation for Clinical Nanomedicine (CLINAM), Basel (CH) Prof. Dr. Gert Storm, Institute for Pharmaceutical Sciences, Utrecht University, (NL) Prof. Dr. Marisa Papaluca Amati, European Medicines Agency, London (GB) Prof. Dr. med. Janos Szebeni, Bay Zoltan Ltd and Semmelweis/Miskolc Universities, Budapest (HU) Prof. Dr. med. Christoph Alexiou, Head and Neck Surgery, University Hospital Erlangen (D) Prof. Dr. Claus-Michael Lehr, Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS), Saarbrucken (D) Prof. Dr. Gerd Binnig, Founder of Definiens AG, Nobel Laureate, Munich (DE) Patrick Boisseau, CEA-Lti, Chairman of the ETPN, Grenoble (FR) Prof. Dr. Viola Vogel, Laboratory for Biologically Oriented Materials, ETH, Zrich (CH) Prof. Dr. Jan Mollenhauer, Director Lundbeckfonden Center of Excellence University of Southern Denmark, Odense (DK) Dr. Yanay Ofran, Systems Biology & Functional Genomics, Bar Ilan University, Ramat Gan (IL)

Conference Venue: Congress Center, Messeplatz 21, 4058 Basel, Switzerland, Phone + 41 58 206 28 28 This email address is being protected from spambots. You need JavaScript enabled to view it.

See original here:
CLINAM - Introduction

Innovative Report on Nanomedicine Market with Focusing on Eminent Players- Nanosphere Inc.,Pfizer Inc.,Combimatrix Corp – Finance Daily Tribune

Posted on by

Global Nanomedicine Market research report from Crystal Market Research covers overview defines characteristics, size and growth, segmentation, regional breakdowns, competitive landscape, market share, trends and strategies for the Nanomedicine industry.The size section gives the revenues, covering both the historic data of the Nanomedicine market and forecasting the future. Drivers and restraints are studied with respect to external factors influencing the growth of the market.

The authors of the Nanomedicine report shed light on lucrative business prospects, prominent trends, regulatory situations, and price scenarios of the global Nanomedicine market. Importantly, the report gives a detailed analysis of macroeconomic and microeconomics factors impacting the growth of the global Nanomedicine market. It is divided into various sections and chapters to help with easy understanding of each and every aspect of the global Nanomedicine market.

Click Here To Access The Sample Report @https://www.crystalmarketresearch.com/report-sample/HC122205

Continue

Check Exclusive Discount on this report @https://www.crystalmarketresearch.com/check-discount/HC122205

To get this report at a profitable rate @ https://www.crystalmarketresearch.com/send-an-enquiry/HC122205

Contacts Us:

Sherry | APAC Marketing Division: Level 23-1, Premier Suite

Mont Kiara, 50480 Kuala Lumpur

Malaysia

E-mail: sales@crystalmarketresearch.com

See the article here:
Innovative Report on Nanomedicine Market with Focusing on Eminent Players- Nanosphere Inc.,Pfizer Inc.,Combimatrix Corp - Finance Daily Tribune

Researchers Find Nanotoxicity Studies May Be Affected by Nanoparticles Staying Behind in Syringes – Lexology

Posted on by

On November 25, 2019, the European Union (EU) Observatory for Nanomaterials (EUON) announced the publication of a study published in Frontiers in Pharmacology entitled Unpredictable Nanoparticle Retention in Commonly Used Plastic Syringes Introduces Dosage Uncertainties That May Compromise the Accuracy of Nanomedicine and Nanotoxicology Studies. The researchers in the study radiolabeled a variety of different nanoparticles, loaded suspensions of particles into different plastic syringes, and then measured the radioactivity left behind after emptying the nanoparticle suspension from the syringe. This provided a simple way to measure the fraction of nanoparticles that remained stuck inside the syringe. According to EUON, in the worst case, up to 79.1 percent of the nanoparticles remained. The study found variability in the amounts remaining behind depending on the types of particles and syringes used. The researchers propose checks to determine the correct combination of syringe and nanoparticle that should be used to minimize the problem. The study did not identify the root causes of the high variability between the different nanoparticles and syringe types used.

Go here to see the original:
Researchers Find Nanotoxicity Studies May Be Affected by Nanoparticles Staying Behind in Syringes - Lexology

COVID-19 impact on Nanorobotics Market Research, Development, Top Companies, Trends and Growth 2020 to 2025: Bruker, JEOL, Thermo Fisher Scientific -…

Posted on by

Chicago, United States: The report comes out as an intelligent and thorough assessment tool as well as a great resource that will help you to secure a position of strength in the globalNanorobotics MarketMarket. It includes Porters Five Forces and PESTLE analysis to equip your business with critical information and comparative data about the Global Nanorobotics Market Market. We have provided deep analysis of the vendor landscape to give you a complete picture of current and future competitive scenarios of the global Nanorobotics Market market. Our analysts use the latest primary and secondary research techniques and tools to prepare comprehensive and accurate market research reports.

Top Key players cited in the report: Bruker, JEOL, Thermo Fisher Scientific, Ginkgo Bioworks, Oxford Instruments, EV Group, Imina Technologies, Toronto Nano Instrumentation, Klocke Nanotechnik, Kleindiek Nanotechnik

The final report will add the analysis of the Impact of Covid-19 in this report Nanorobotics MarketMarket

Get PDF Sample Copy of this Report to understand the structure of the complete report: (Including Full TOC, List of Tables & Figures, Chart)

Segmentation by Application: Nanomedicine, Biomedical, Mechanical

Segmentation by Type:Nanomanipulator, Bio-Nanorobotics, Magnetically Guided, Bacteria-Based

Each segment of the global Nanorobotics Market market is extensively evaluated in the research study. The segmental analysis offered in the report pinpoints key opportunities available in the global Nanorobotics Market market through leading segments. The regional study of the global Nanorobotics Market market included in the report helps readers to gain a sound understanding of the development of different geographical markets in recent years and also going forth. We have provided a detailed study on the critical dynamics of the global Nanorobotics Market market, which include the market influence and market effect factors, drivers, challenges, restraints, trends, and prospects. The research study also includes other types of analysis such as qualitative and quantitative.

Global Nanorobotics Market Market: Competitive Rivalry

The chapter on company profiles studies the various companies operating in the global Nanorobotics Market market. It evaluates the financial outlooks of these companies, their research and development statuses, and their expansion strategies for the coming years. Analysts have also provided a detailed list of the strategic initiatives taken by the Nanorobotics Market market participants in the past few years to remain ahead of the competition.

Global Nanorobotics Market Market: Regional Segments

The chapter on regional segmentation details the regional aspects of the global Nanorobotics Market market. This chapter explains the regulatory framework that is likely to impact the overall market. It highlights the political scenario in the market and the anticipates its influence on the global Nanorobotics Market market.

The Middle East and Africa(GCC Countries and Egypt)North America(the United States, Mexico, and Canada)South America(Brazil etc.)Europe(Turkey, Germany, Russia UK, Italy, France, etc.)Asia-Pacific(Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia, and Australia)

Request For Customization:https://www.reporthive.com/request_customization/2296484

Report Highlights

Comprehensive pricing analysis on the basis of product, application, and regional segments

The detailed assessment of the vendor landscape and leading companies to help understand the level of competition in the global Nanorobotics Market market

Deep insights about regulatory and investment scenarios of the global Nanorobotics Market market

Analysis of market effect factors and their impact on the forecast and outlook of the global Nanorobotics Market market

A roadmap of growth opportunities available in the global Nanorobotics Market market with the identification of key factors

The exhaustive analysis of various trends of the global Nanorobotics Market market to help identify market developments

Table of Contents

Report Overview:It includes six chapters, viz. research scope, major manufacturers covered, market segments by type, Nanorobotics Market market segments by application, study objectives, and years considered.

Global Growth Trends:There are three chapters included in this section, i.e. industry trends, the growth rate of key producers, and production analysis.

Nanorobotics Market Market Share by Manufacturer:Here, production, revenue, and price analysis by the manufacturer are included along with other chapters such as expansion plans and merger and acquisition, products offered by key manufacturers, and areas served and headquarters distribution.

Market Size by Type:It includes analysis of price, production value market share, and production market share by type.

Market Size by Application:This section includes Nanorobotics Market market consumption analysis by application.

Profiles of Manufacturers:Here, leading players of the global Nanorobotics Market market are studied based on sales area, key products, gross margin, revenue, price, and production.

Nanorobotics Market Market Value Chain and Sales Channel Analysis:It includes customer, distributor, Nanorobotics Market market value chain, and sales channel analysis.

Market Forecast Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.

Get Free Sample Copy of this report: https://www.reporthive.com/request_sample/2296484

About Us:Report Hive Research delivers strategic market research reports, statistical survey, and Industry analysis and forecast data on products and services, markets and companies. Our clientele ranges mix of United States Business Leaders, Government Organizations, SMEs, Individual and Start-ups, Management Consulting Firms, and Universities etc. Our library of 600,000+ market reports covers industries like Chemical, Healthcare, IT, Telecom, Semiconductor, etc. in the USA, Europe Middle East, Africa, Asia Pacific. We help in business decision-making on aspects such as market entry strategies, market sizing, market share analysis, sales and revenue, technology trends, competitive analysis, product portfolio and application analysis etc.

Link:
COVID-19 impact on Nanorobotics Market Research, Development, Top Companies, Trends and Growth 2020 to 2025: Bruker, JEOL, Thermo Fisher Scientific -...

Healthcare Nanotechnology (Nanomedicine) Market Analysis, Top Manufacturers, Share, Growth, Statistics, Opportunities and Forecast To 2026 – Cole of…

Posted on by

New Jersey, United States,- A detailed research study on Healthcare Nanotechnology (Nanomedicine) Market recently published by Market Research Intellect. This is the latest report, which covers the time COVID-19 impact on the market. Pandemic Coronavirus (COVID-19) has affected every aspect of global life. This has brought some changes in market conditions. Rapidly changing market scenario and the initial assessment and the future of this effect is included in the report. Reports put together a brief analysis of the factors affecting the growth of the current business scenarios in various areas. Important information relating to the size of the industry analysis, sharing, application, and statistics summed up in the report to present the ensemble prediction. In addition, this report includes an accurate competitive analysis of major market players and their strategies during the projection period.

This report includes market size estimates for the value (million USD) and volume (K Units). Both top-down and bottom-up approach has been used to estimate the size of the market and validate the Market of Healthcare Nanotechnology (Nanomedicine), to estimate the size of the various submarkets more dependent on the overall market. Key players in the market have been identified through secondary research and their market share has been determined through primary and secondary research. All the shares percentage, split, and the damage have been determined using secondary sources and primary sources verified.

Get Sample Copy with TOC of the Report to understand the structure of the complete report @ https://www.marketresearchintellect.com/download-sample/?rid=210503&utm_source=COD&utm_medium=888

Leading Healthcare Nanotechnology (Nanomedicine) manufacturers/companies operating at both regional and global levels:

Healthcare Nanotechnology (Nanomedicine) Market Competitive Landscape & Company Profiles

Competitor analysis is one of the best sections of the report that compares the progress of leading players based on crucial parameters, including market share, new developments, global reach, local competition, price, and production. From the nature of competition to future changes in the vendor landscape, the report provides in-depth analysis of the competition in the Healthcare Nanotechnology (Nanomedicine) market.

Segmental Analysis

Both developed and emerging regions are deeply studied by the authors of the report. The regional analysis section of the report offers a comprehensive analysis of the global Healthcare Nanotechnology (Nanomedicine) market on the basis of region. Each region is exhaustively researched about so that players can use the analysis to tap into unexplored markets and plan powerful strategies to gain a foothold in lucrative markets.

Healthcare Nanotechnology (Nanomedicine) Market, By Product

Healthcare Nanotechnology (Nanomedicine) Market, By Application

Regions Covered in these Report:

Asia Pacific (China, Japan, India, and Rest of Asia Pacific)Europe (Germany, the UK, France, and Rest of Europe)North America (the US, Mexico, and Canada)Latin America (Brazil and Rest of Latin America)Middle East & Africa (GCC Countries and Rest of Middle East & Africa)

To get Incredible Discounts on this Premium Report, Click Here @ https://www.marketresearchintellect.com/ask-for-discount/?rid=210503&utm_source=COD&utm_medium=888

Healthcare Nanotechnology (Nanomedicine) Market Research Methodology

The research methodology adopted for the analysis of the market involves the consolidation of various research considerations such as subject matter expert advice, primary and secondary research. Primary research involves the extraction of information through various aspects such as numerous telephonic interviews, industry experts, questionnaires and in some cases face-to-face interactions. Primary interviews are usually carried out on a continuous basis with industry experts in order to acquire a topical understanding of the market as well as to be able to substantiate the existing analysis of the data.

Subject matter expertise involves the validation of the key research findings that were attained from primary and secondary research. The subject matter experts that are consulted have extensive experience in the market research industry and the specific requirements of the clients are reviewed by the experts to check for completion of the market study. Secondary research used for the Healthcare Nanotechnology (Nanomedicine) market report includes sources such as press releases, company annual reports, and research papers that are related to the industry. Other sources can include government websites, industry magazines and associations for gathering more meticulous data. These multiple channels of research help to find as well as substantiate research findings.

Table of Content

1 Introduction of Healthcare Nanotechnology (Nanomedicine) Market

1.1 Overview of the Market1.2 Scope of Report1.3 Assumptions

2 Executive Summary

3 Research Methodology

3.1 Data Mining3.2 Validation3.3 Primary Interviews3.4 List of Data Sources

4 Healthcare Nanotechnology (Nanomedicine) Market Outlook

4.1 Overview4.2 Market Dynamics4.2.1 Drivers4.2.2 Restraints4.2.3 Opportunities4.3 Porters Five Force Model4.4 Value Chain Analysis

5 Healthcare Nanotechnology (Nanomedicine) Market, By Deployment Model

5.1 Overview

6 Healthcare Nanotechnology (Nanomedicine) Market, By Solution

6.1 Overview

7 Healthcare Nanotechnology (Nanomedicine) Market, By Vertical

7.1 Overview

8 Healthcare Nanotechnology (Nanomedicine) Market, By Geography

8.1 Overview8.2 North America8.2.1 U.S.8.2.2 Canada8.2.3 Mexico8.3 Europe8.3.1 Germany8.3.2 U.K.8.3.3 France8.3.4 Rest of Europe8.4 Asia Pacific8.4.1 China8.4.2 Japan8.4.3 India8.4.4 Rest of Asia Pacific8.5 Rest of the World8.5.1 Latin America8.5.2 Middle East

9 Healthcare Nanotechnology (Nanomedicine) Market Competitive Landscape

9.1 Overview9.2 Company Market Ranking9.3 Key Development Strategies

10 Company Profiles

10.1.1 Overview10.1.2 Financial Performance10.1.3 Product Outlook10.1.4 Key Developments

11 Appendix

11.1 Related Research

Customized Research Report Using Corporate Email Id @ https://www.marketresearchintellect.com/need-customization/?rid=210503&utm_source=COD&utm_medium=888

About Us:

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations with the aim of delivering functional expertise. We provide reports for all industries including Energy, Technology, Manufacturing and Construction, Chemicals and Materials, Food and Beverage and more. These reports deliver an in-depth study of the market with industry analysis, market value for regions and countries and trends that are pertinent to the industry.

Contact Us:

Mr. Steven Fernandes

Market Research Intellect

New Jersey ( USA )

Tel: +1-650-781-4080

Our Trending Reports

Printed Cartons Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Printed Sensor Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Printing for Packaging Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

See the original post:
Healthcare Nanotechnology (Nanomedicine) Market Analysis, Top Manufacturers, Share, Growth, Statistics, Opportunities and Forecast To 2026 - Cole of...

Healthcare Nanotechnology (Nanomedicine) Market Overview, Top Companies, Region, Application and Global Forecast by 2026 – Latest Herald

Posted on by

Endo International

Global Healthcare Nanotechnology (Nanomedicine) Market Segmentation

This market was divided into types, applications and regions. The growth of each segment provides an accurate calculation and forecast of sales by type and application in terms of volume and value for the period between 2020 and 2026. This analysis can help you develop your business by targeting niche markets. Market share data are available at global and regional levels. The regions covered by the report are North America, Europe, the Asia-Pacific region, the Middle East, and Africa and Latin America. Research analysts understand the competitive forces and provide competitive analysis for each competitor separately.

To get Incredible Discounts on this Premium Report, Click Here @ https://www.marketresearchintellect.com/ask-for-discount/?rid=210503&utm_source=LHN&utm_medium=888

Healthcare Nanotechnology (Nanomedicine) Market Region Coverage (Regional Production, Demand & Forecast by Countries etc.):

North America (U.S., Canada, Mexico)

Europe (Germany, U.K., France, Italy, Russia, Spain etc.)

Asia-Pacific (China, India, Japan, Southeast Asia etc.)

South America (Brazil, Argentina etc.)

Middle East & Africa (Saudi Arabia, South Africa etc.)

Some Notable Report Offerings:

-> We will give you an assessment of the extent to which the market acquire commercial characteristics along with examples or instances of information that helps your assessment.

-> We will also support to identify standard/customary terms and conditions such as discounts, warranties, inspection, buyer financing, and acceptance for the Healthcare Nanotechnology (Nanomedicine) industry.

-> We will further help you in finding any price ranges, pricing issues, and determination of price fluctuation of products in Healthcare Nanotechnology (Nanomedicine) industry.

-> Furthermore, we will help you to identify any crucial trends to predict Healthcare Nanotechnology (Nanomedicine) market growth rate up to 2026.

-> Lastly, the analyzed report will predict the general tendency for supply and demand in the Healthcare Nanotechnology (Nanomedicine) market.

Have Any Query? Ask Our Expert@ https://www.marketresearchintellect.com/need-customization/?rid=210503&utm_source=LHN&utm_medium=888

Table of Contents:

Study Coverage: It includes study objectives, years considered for the research study, growth rate and Healthcare Nanotechnology (Nanomedicine) market size of type and application segments, key manufacturers covered, product scope, and highlights of segmental analysis.

Executive Summary: In this section, the report focuses on analysis of macroscopic indicators, market issues, drivers, and trends, competitive landscape, CAGR of the global Healthcare Nanotechnology (Nanomedicine) market, and global production. Under the global production chapter, the authors of the report have included market pricing and trends, global capacity, global production, and global revenue forecasts.

Healthcare Nanotechnology (Nanomedicine) Market Size by Manufacturer: Here, the report concentrates on revenue and production shares of manufacturers for all the years of the forecast period. It also focuses on price by manufacturer and expansion plans and mergers and acquisitions of companies.

Production by Region: It shows how the revenue and production in the global market are distributed among different regions. Each regional market is extensively studied here on the basis of import and export, key players, revenue, and production.

About Us:

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations with the aim of delivering functional expertise. We provide reports for all industries including Energy, Technology, Manufacturing and Construction, Chemicals and Materials, Food and Beverage and more. These reports deliver an in-depth study of the market with industry analysis, market value for regions and countries and trends that are pertinent to the industry.

Contact Us:

Mr. Steven Fernandes

Market Research Intellect

New Jersey ( USA )

Tel: +1-650-781-4080

Tags: Healthcare Nanotechnology (Nanomedicine) Market Size, Healthcare Nanotechnology (Nanomedicine) Market Growth, Healthcare Nanotechnology (Nanomedicine) Market Forecast, Healthcare Nanotechnology (Nanomedicine) Market Analysis

Our Trending Reports

Probiotics in Animal Feed Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Product Compliance Software Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Continue reading here:
Healthcare Nanotechnology (Nanomedicine) Market Overview, Top Companies, Region, Application and Global Forecast by 2026 - Latest Herald

MagForce AG: MagForce USA, Inc. has received FDA Approval to proceed with its Streamlined Trial Prot – PharmiWeb.com

Posted on by

MagForce AG / Key word(s): StudyMagForce AG: MagForce USA, Inc. has received FDA Approval to proceed with its Streamlined Trial Protocol for the next Stage of Pivotal U.S. Single-Arm Study for the Focal Ablation of Intermediate Risk Prostate Cancer with the NanoTherm Therapy System

27-Apr-2020 / 23:51 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.

MagForce AG: MagForce USA, Inc. has received FDA Approval to proceed with its Streamlined Trial Protocol for the next Stage of Pivotal U.S. Single-Arm Study for the Focal Ablation of Intermediate Risk Prostate Cancer with the NanoTherm Therapy System

Berlin, Germany, and Nevada, USA, April 27, 2020 - MagForce AG (Frankfurt, Scale, Xetra: MF6, ISIN: DE000A0HGQF5), a leading medical device company in the field of nanomedicine focused on oncology, together with its subsidiary MagForce USA, Inc., today announced that FDA approval for a streamlined trial protocol, for the next stage of the Company's pivotal U.S. study with the NanoTherm therapy system for the focal ablation of intermediate risk prostate cancer was received. The next stage of the clinical trial is being initiated with three well-respected urological centers in Texas, Washington and Florida who actively enrolled patients in Stage 1.

The streamlined procedure will allow the patient treatment to be completed within one day at one of MagForce's three out-patient treatment facilities and is possible because of limited side effects that were observed at each step of the procedure in Stage 1.

The next stage of the study will be conducted in phases to ensure early on that the minimal side effects observed in Stage 1, with a drawn out procedure, are maintained in the streamlined one day procedure. Treatment of the first 5 to10 subjects should be sufficient to affirm the minimal side effects as expected.

COVID-19 impact: While there are many restrictions that have been applied such as "Shelter at Home" and eliminating state to state travel via car or via plane; however, MagForce is still working diligently with its physician investigators. Exemptions exist for healthcare workers, such as MagForce's USA staff at MagForce USA clinical facilities. Clearly MagForce USA can conduct the trial in its out-patient facilities and has developed COVID-19 infection control procedures for staff and study subjects. All this effort has caused a certain delay but MagForce is confident the next stage of the clinical trial will not be unduly delayed since MagForce USA will conduct the trial from its facilities.

MagForce is still hopeful that the COVID-19 pandemic will not cause significant delay beyond 2020 to complete this single-arm clinical trial.

- End of Insider Information -

Contact:MagForce AG, Max-Planck-Strae 3, 12489 BerlinBarbara von FrankenbergVice President Communications & Investor RelationsT +49-30-308380-77E-Mail: bfrankenberg@magforce.com

Disclaimer

This release may contain forward-looking statements and information which may be identified by formulations using terms such as "expects", "aims", "anticipates", "intends", "plans", "believes", "seeks", "estimates" or "will". Such forward-looking statements are based on our current expectations and certain assumptions, which may be subject to a variety of risks and uncertainties. The results actually achieved by MagForce AG may substantially differ from these forward-looking statements. MagForce AG assumes no obligation to update these forward-looking statements or to correct them in case of developments, which differ from those, anticipated.

27-Apr-2020 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at http://www.dgap.de

Read the original:
MagForce AG: MagForce USA, Inc. has received FDA Approval to proceed with its Streamlined Trial Prot - PharmiWeb.com

Impact of COVID-19 Outbreak on Contrast Agents for Magnetic Resonance Imaging (MRI) Market Analysis 2019 Growth by Top Companies and Trends by Types,…

Posted on by

In 2018, the market size of Contrast Agents for Magnetic Resonance Imaging (MRI) Market is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2018; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.

The report on the Contrast Agents for Magnetic Resonance Imaging (MRI) market provides a birds eye view of the current proceeding within the Contrast Agents for Magnetic Resonance Imaging (MRI) market. Further, the report also takes into account the impact of the novel COVID-19 pandemic on the Contrast Agents for Magnetic Resonance Imaging (MRI) market and offers a clear assessment of the projected market fluctuations during the forecast period. The different factors that are likely to impact the overall dynamics of the Contrast Agents for Magnetic Resonance Imaging (MRI) market over the forecast period (2019-2029) including the current trends, growth opportunities, restraining factors, and more are discussed in detail in the market study.

Get Free Sample PDF (including COVID19 Impact Analysis, full TOC, Tables and Figures) of Market Report @ https://www.researchmoz.com/enquiry.php?type=S&repid=2554066&source=atm

This study presents the Contrast Agents for Magnetic Resonance Imaging (MRI) Market production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. Contrast Agents for Magnetic Resonance Imaging (MRI) history breakdown data from 2014 to 2018, and forecast to 2025.

For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2018.

In global Contrast Agents for Magnetic Resonance Imaging (MRI) market, the following companies are covered:

The following manufacturers are covered:GE Healthcare (US)Bracco Imaging (Italy)Bayer HealthCare (Germany)Guerbet (France)Lantheus (US)Daiichi Sankyo (Japan)Unijules Life Sciences (India)J.B. Chemicals and Pharmaceuticals (India)Spago Nanomedicine (Sweden)Taejoon Pharm (South Korea)Jodas (India)Magnus Health (India)

Segment by RegionsNorth AmericaEuropeChinaJapanSoutheast AsiaIndia

Segment by TypeBarium-based Contrast MediaIodinated Contrast MediaGadolinium-based Contrast MediaMicrobubble Contrast Media

Segment by ApplicationRadiologyInterventional RadiologyInterventional Cardiology

Do You Have Any Query Or Specific Requirement? Ask to Our Industry [emailprotected] https://www.researchmoz.com/enquiry.php?type=E&repid=2554066&source=atm

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Contrast Agents for Magnetic Resonance Imaging (MRI) product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Contrast Agents for Magnetic Resonance Imaging (MRI) , with price, sales, revenue and global market share of Contrast Agents for Magnetic Resonance Imaging (MRI) in 2017 and 2018.

Chapter 3, the Contrast Agents for Magnetic Resonance Imaging (MRI) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Contrast Agents for Magnetic Resonance Imaging (MRI) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2018.

Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2018.

You can Buy This Report from Here @ https://www.researchmoz.com/checkout?rep_id=2554066&licType=S&source=atm

Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2018.

Chapter 12, Contrast Agents for Magnetic Resonance Imaging (MRI) market forecast, by regions, type and application, with sales and revenue, from 2018 to 2024.

Chapter 13, 14 and 15, to describe Contrast Agents for Magnetic Resonance Imaging (MRI) sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Original post:
Impact of COVID-19 Outbreak on Contrast Agents for Magnetic Resonance Imaging (MRI) Market Analysis 2019 Growth by Top Companies and Trends by Types,...

Taiwan’s AI thermometer draws interest in SE Asia – Taiwan News

Posted on by

Taiwan develops AI infrared thermometer. (NHRI image) Taiwan develops AI infrared thermometer. (NHRI image)

TAIPEI (Taiwan News) Many Southeast Asian nations have expressed interest in acquiring a next-generation infrared thermometer developed by Taiwan that is being touted as smart and able to reduce erroneous readings.

Designed by the National Health Research Institutes (NHRI), a government-sponsored and mission-oriented medical research center, the thermometer incorporates artificial intelligence (AI) technologies.

The AI feature allows the device to detect people's faces before reading their temperatures, which reduces errors due to interference by radiation emitted from objects held by the individual being measured for example, a cup of hot coffee or cold drink. The feature is particularly commercially attractive at a time when countries around the world are deploying thermometers to screen suspected patients of the coronavirus.

Compared to other types of contactless thermometer, the system delivered satisfactory results in an experiment of 200 people in open spaces, said Liao Lun-de (), assistant investigator of NHRIs Institute of Biomedical Engineering and Nanomedicine. The masks, hats, and glasses the individuals wore were not found to have affected the temperature readings.

The device will sound an alarm and automatically take photos of individuals whose temperatures exceed a certain level. The alerts will be dispatched to disease control staff so they can respond in an efficient and timely fashion.

The mechanism, which integrates real-time thermal sensor software and AI neuroscience, among other technologies, is also cost-competitive, as some thermometers are priced at over NT$200,000 (US$6,653) a unit, said Liao.

Continued here:
Taiwan's AI thermometer draws interest in SE Asia - Taiwan News

Nanomedicine Market: Industry Analysis and forecast 2026 – Research Columnist

Posted on by

Nanomedicine Marketwas valued US$ XX Bn in 2018 and is expected to reach US$ XX Bn by 2026, at CAGR of XX% during forecast period of 2019 to 2026.

The report study has analyzed revenue impact of covid-19 pandemic on the sales revenue of market leaders, market followers and disrupters in the report and same is reflected in our analysis.

Nanomedicine Market Drivers and Restrains:Nanomedicine is an application of nanotechnology, which are used in diagnosis, treatment, monitoring, and control of biological systems. Nanomedicine usages nanoscale manipulation of materials to improve medicine delivery. Therefore, nanomedicine has facilitated the treatment against various diseases. The nanomedicine market includes products that are nanoformulations of the existing drugs and new drugs or are nanobiomaterials. The research and development of new devices as well as the diagnostics will become, more effective, enabling faster response and the ability to treat new diseases are likely to boost the market growth.

REQUEST FOR FREE SAMPLE REPORT:https://www.maximizemarketresearch.com/request-sample/39223/

The nanomedicine markets are driven by factors such as developing new technologies for drug delivery, increase acceptance of nanomedicine across varied applications, rise in government support and funding, the growing need for therapies that have fewer side effects and cost-effective. However, long approval process and risks associated with nanomedicine (environmental impacts) are hampering the market growth at the global level. An increase in the out-licensing of nanodrugs and growth of healthcare facilities in emerging economies are likely to create lucrative opportunities in the nanomedicine market.

Nanomedicine Market Segmentation Analysis:Based on the application, the nanomedicine market has been segmented into cardiovascular, neurology, anti-infective, anti-inflammatory, and oncology. The oncology segment held the dominant market share in 2018 and is projected to maintain its leading position throughout the forecast period owing to the rising availability of patient information and technological advancements. However, the cardiovascular and neurology segment is projected to grow at the highest CAGR of XX% during the forecast period due to presence of opportunities such as demand for specific therapeutic nanovectors, nanostructured stents, and implants for tissue regeneration.

Nanomedicine Market Regional Analysis:Geographically, the Nanomedicine market has been segmented into North America, the Europe, Asia Pacific, Latin America, and Middle East & Africa. North America held the largest share of the Nanomedicine market in 2018 due to the rising presence of patented nanomedicine products, the availability of advanced healthcare infrastructure and the rapid acceptance of nanomedicine. The market in Asia Pacific is expected to expand at a high CAGR of XX% during the forecast period thanks to rise in number of research grants and increase in demand for prophylaxis of life-threatening diseases. Moreover, the rising investments in research and development activities for the introduction of advanced therapies and drugs are predicted to accelerate the growth of this region in the near future.

DO INQUIRY BEFORE PURCHASING REPORT HERE:https://www.maximizemarketresearch.com/inquiry-before-buying/39223/

Nanomedicine Market Competitive landscapeMajor Key players operating in this market are Abbott Laboratories, CombiMatrix Corporation, General Electric Company, Sigma-Tau Pharmaceuticals, Inc, and Johnson & Johnson. Manufacturers in the nanomedicine are focusing on competitive pricing as the strategy to capture significant market share. Moreover, strategic mergers and acquisitions and technological innovations are also the key focus areas of the manufacturers.

The objective of the report is to present a comprehensive analysis of Nanomedicine Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all aspects of the industry with a dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market are presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding Nanomedicine Market dynamics, structure by analyzing the market segments and project the Nanomedicine Market size. Clear representation of competitive analysis of key players By Type, Price, Financial position, Product portfolio, Growth strategies, and regional presence in the Nanomedicine Market make the report investors guide.Scope of the Nanomedicine Market:

Nanomedicine Market by Modality:

Diagnostics TreatmentsNanomedicine Market by Diseases:

Oncological Diseases Infectious Diseases Cardiovascular Diseases Orthopedic Disorders Neurological Diseases Urological Diseases Ophthalmological Diseases Immunological DiseasesNanomedicine Market by Application:

Neurology Cardiovascular Anti-Inflammatory Anti-Infectives OncologyNanomedicine Market by Region:

Asia Pacific North America Europe Latin America Middle East AfricaNanomedicine Market Major Players:

Abbott Laboratories CombiMatrix Corporation General Electric Company Sigma-Tau Pharmaceuticals, Inc Johnson & Johnson Mallinckrodt plc. Merck & Company, Inc. Nanosphere, Inc. Pfizer, Inc. Teva Pharmaceutical Industries Ltd. Celgene Corporation UCB (Union Chimique Belge) S.A. AMAG Pharmaceuticals Nanospectra Biosciences, Inc. Arrowhead Pharmaceuticals, Inc. Leadiant Biosciences, Inc. Epeius Biotechnologies Corporation Cytimmune Sciences, Inc.

MAJOR TOC OF THE REPORT

Chapter One: Nanomedicine Market Overview

Chapter Two: Manufacturers Profiles

Chapter Three: Global Nanomedicine Market Competition, by Players

Chapter Four: Global Nanomedicine Market Size by Regions

Chapter Five: North America Nanomedicine Revenue by Countries

Chapter Six: Europe Nanomedicine Revenue by Countries

Chapter Seven: Asia-Pacific Nanomedicine Revenue by Countries

Chapter Eight: South America Nanomedicine Revenue by Countries

Chapter Nine: Middle East and Africa Revenue Nanomedicine by Countries

Chapter Ten: Global Nanomedicine Market Segment by Type

Chapter Eleven: Global Nanomedicine Market Segment by Application

Chapter Twelve: Global Nanomedicine Market Size Forecast (2019-2026)

Browse Full Report with Facts and Figures of Nanomedicine Market Report at:https://www.maximizemarketresearch.com/market-report/nanomedicine-market/39223/

About Us:

Maximize Market Research provides B2B and B2C market research on 20,000 high growth emerging technologies & opportunities in Chemical, Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.

Contact info:

Name: Lumawant Godage

Organization: MAXIMIZE MARKET RESEARCH PVT. LTD.

Email: sales@maximizemarketresearch.com

Contact: +919607065656/ +919607195908

Website: http://www.maximizemarketresearch.com

Originally posted here:
Nanomedicine Market: Industry Analysis and forecast 2026 - Research Columnist

A new, inhaled siRNA therapeutic option for asthma – Advanced Science News

Posted on by

Share

Share

Email

After more than 20 years of research, we are now witnessing a breakthrough of small interfering RNA (siRNA)-based therapies. In 2018, the first-ever siRNA drug, Onpattro, reached the market, followed by the approval of Givlaari in 2019, and many other clinical trials are in progress.

Holding the potential to treat a wide range of diseases from cancer to immunological disorders, siRNA therapeutics have received plenty of attention. With the support of a suitable delivery system, they can be directed to downregulate a specific target gene. Both approved siRNA drugs Onpattro and Givlaari are only able to reach the liver, however. Other organs that can be treated by loco-regional administration, such as the lung, are, in principle, good targets for siRNA therapies as well.

In this view, siRNA-baseddrugs could not only act as an ally in the battle against the current COVID-19pandemic but also against other severe lung diseases such as asthma. Despitethe great advances in asthma treatment, this disease still represents an unmetmedical need in about 510% of patients.Moreover, most of the available drugs work symptomatically rather than causally.

In a recent article published in WIREs Nanomedicine and Nanobiotechnology, Domizia Baldassi and Tobias Keil, graduate students in Prof. Olivia Merkels research group at the University of Munich, discuss the groups advances towards developing a nanocarrier that can deliver siRNA into T cells in the lung.

The aim of T-cell delivery is downregulation of GATA-3, the transcription factor of T helper 2 (TH2) cells overexpressed in asthmatic patients, which is recognized as a key factor in the asthmatic inflammatory cascade. Based on their observation that transferrin receptor is overexpressed in activated T cells, the researchers sought to find a virus-like tool to target activated TH2 cells specifically and efficiently in a receptor-mediated manner.

They accomplishedthis goal by creating a conjugate formed by transferrin and low-molecular-weightpolyethylenimine (Tf-PEI). On the one hand, they used a well-known cationic polymerto electrostatically interact with the negatively charged siRNA and protect itfrom degradation during the journey through the airways. And on the other hand,transferrin served as a targeting moiety to mediate a specific, targeteddelivery of siRNA only to activated T cells.

Since theendosomal escape is considered the rate-limiting step in cytoplasmaticdelivery of nanoparticle-based therapies, improving this aspect of theformulation was the focus, and Tf-PEI was blended with a second conjugatecomposed of melittin and PEI (Mel-PEI). Melittin is a well-known membranolyticagent from bee venom that was chemically modified to react in a pH-dependentmanner.

The researchersexploited the intrinsic lytic characteristic of the peptide to improve therelease of siRNA into the cytosol, reaching knockdown levels as high as 70% exvivo. But further steps such as the validation of these results in vivo on anasthma mouse model are needed, as well as possible alternative polymericmaterials.

In the process of developing a new pharmaceutical product, it is crucial to keep the administration route in mind. Spray drying is the most straightforward technique to produce inhalable particles for pulmonary delivery, according to the researchers. In a proof-of-concept study, they obtained nano-in-microparticles by spray drying PEI-pDNA polyplexes together with a cryoprotectant agent. After seeing promising results, their studies to obtain a dry powder formulation of siRNA-based polyplexes are ongoing.

Ultimately, both research fields will be combined and hopefully result in a new therapy for the treatment of severe, uncontrolled asthma and many other lung diseases, concluded Baldassi, Keil, and Merkel.

Reference: Tobias W. M. Keil et al. T-cell targeted pulmonary siRNA delivery for the treatment of asthma. WIREs Nanomedicine and Nanobiotechnology (2020). DOI: 10.1002/10.1002/wnan.1634

Link:
A new, inhaled siRNA therapeutic option for asthma - Advanced Science News

University of Waterloo researchers developing non-invasive COVID-19 vaccine – Toronto Sun

Posted on by

A new, non-invasive COVID-19 vaccine is being developed by researchers at the University of Waterloo.

The DNA-based vaccine will be delivered as a nasal spray and have both preventative and therapeutic effect.

Dr. Roderick Slavcev, a professor in the School of Pharmacy, explained Wednesday that the vaccine uses bacteriophage the process allows the vaccine to replicate within bacteria already in the body and is being designed to target tissues in the nasal cavity and lower respiratory tract.

Once complete, our DNA-based vaccine delivers nanomedicine engineered to immunize and decrease COVID-19 infections, said Slavcev, who specializes in designing vaccines, pharmaceuticals and gene-therapy treatments.

The genetic cargo to be delivered attaches to receptors in the respiratory tract, where COVID-19 would attach so its competing for the same spots.

Dr. Roderick Slavcev, a professor in the UW School of Pharmacy.

The DNA vaccine, he adds, will both stimulate an immune response, firing up the bodys capacity to fight off COVID-19, and also prevent further infection.

The vaccine enters cells in targeted tissues and causes them to produce a virus-like particle (VLP) that will stimulate an immune response.

The VLP will look similar to the structure of SARS-CoV-2 the virus which causes COVID-19 but is harmless. However, the similarity activates the bodys natural immune response to protect against viral infections comparable to the VLP, including SARS-CoV-2. In binding to the same receptors that SARS-CoV-2 would bind to, it limits possible sites for transmission.

In this way, the vaccine can build immunity against COVID-19 and decrease the severity of infections in progress, working as a therapeutic and a vaccine.

Said Slavcev, Its a cool way to mimic a virus for maximal protection.

Slavcev is teaming up with Emmanuel Ho, another professor at the School of Pharmacy, and Marc Aucoin, professor of chemical engineering.

Hos team is designing the nanomedication that will be delivered by the nasal spray, which is currently being tested. Aucoins lab is constructing and purifying the VLP and boosting immunity following the initial administration of the therapeutic vaccine.

Asked for a time line, Slavcev said, We are expediting quickly. We anticipate going to animal trials within six months and hope to have completed them by May of 2021.

lbraun@postmedia.com

Continue reading here:
University of Waterloo researchers developing non-invasive COVID-19 vaccine - Toronto Sun

NANOBIOTIX Announces Fast Track Designation Granted By U.S. FDA For Investigation of First-in-class NBTXR3 In Head and Neck Cancer – Business Wire

Posted on by

PARIS & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Regulatory News:

NANOBIOTIX (Paris:NANO) (Euronext: NANO - ISIN: FR0011341205 the Company), a clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for the investigation of NBTXR3 activated by radiation therapy, with or without cetuximab, for the treatment of patients with locally advanced head and neck squamous cell cancer who are not eligible for platinum-based chemotherapy.

Fast Track is a process designed to facilitate the development and accelerate the review of drugs for serious conditions and that have the potential to address unmet medical needs. The purpose is to expedite the availability of new treatment options for patients.

A product that receives Fast Track designation is eligible for1:

About NBTXR3

NBTXR3 is a first-in-class product designed to destroy tumors through physical cell death when activated by radiotherapy. NBTXR3 has a high degree of biocompatibility, requires one single administration before the first radiotherapy treatment session, and has the ability to fit into current worldwide radiotherapy radiation therapy standards of care. The physical mode of action of NBTXR3 makes it applicable across solid tumors such as lung, prostate, liver, glioblastoma, and breast cancers.

NBTXR3 is actively being evaluated locally advanced head and neck squamous cell carcinoma (HNSCC) of the oral cavity or oropharynx in elderly and frail patients unable to receive chemotherapy or cetuximab with limited therapeutic options. Promising results have been observed in the phase I trial regarding local control. In the United States, the company has started the regulatory process for the clinical authorization of a phase II/III trial in locally advanced head and neck cancers.

Nanobiotix is also running an Immuno-Oncology development program. The Company received FDA approval to launch a clinical trial of NBTXR3 activated by radiotherapy in combination with anti-PD-1 antibodies in locoregional recurrent (LRR) or recurrent and metastatic (R/M) HNSCC amenable to re-irradiation of the HN and lung or liver metastases (mets)from any primary cancer eligible for anti-PD-1.

The other ongoing NBTXR3 trials are treating patients with hepatocellular carcinoma (HCC) or liver metastases, locally advanced or unresectable rectal cancer in combination with chemotherapy, head and neck cancer in combination with concurrent chemotherapy, and prostate adenocarcinoma. Furthermore, the company has a large-scale, comprehensive clinical research collaboration with The University of Texas MD Anderson Cancer Center (9 new phase I/II clinical trials in the United States) to evaluate NBTXR3 across head and neck, pancreatic, thoracic, lung, gastrointestinal and genitourinary cancers.

About NANOBIOTIX: http://www.nanobiotix.com

Incorporated in 2003, Nanobiotix is a leading, clinical-stage nanomedicine company pioneering new approaches to significantly change patient outcomes by bringing nanophysics to the heart of the cell.

The Nanobiotix philosophy is rooted in designing pioneering, physical-based approaches to bring highly effective and generalized solutions to address unmet medical needs and challenges.

Nanobiotixs first-in-class, proprietary lead technology, NBTXR3, aims to expand radiotherapy benefits for millions of cancer patients. Nanobiotixs Immuno-Oncology program has the potential to bring a new dimension to cancer immunotherapies.

Nanobiotix is listed on the regulated market of Euronext in Paris (Euronext: NANO / ISIN: FR0011341205; Bloomberg: NANO: FP). The Companys headquarters are in Paris, France, with a US affiliate in Cambridge, MA, and European affiliates in France, Spain and Germany

1https://www.fda.gov/patients/fast-track-breakthrough-therapy-accelerated-approval-priority-review/fast-track

Disclaimer

This press release contains certain forward-looking statements concerning Nanobiotix and its business, including its prospects and product candidate development. Such forward-looking statements are based on assumptions that Nanobiotix considers to be reasonable. However, there can be no assurance that the estimates contained in such forward-looking statements will be verified, which estimates are subject to numerous risks including the risks set forth in the reference document of Nanobiotix registered with the French Financial Markets Authority (Autorit des Marchs Financiers) under number R.19-018 on April 30, 2019 (a copy of which is available on http://www.nanobiotix.com) and to the development of economic conditions, financial markets and the markets in which Nanobiotix operates. The forward-looking statements contained in this press release are also subject to risks not yet known to Nanobiotix or not currently considered material by Nanobiotix. The occurrence of all or part of such risks could cause actual results, financial conditions, performance or achievements of Nanobiotix to be materially different from such forward-looking statements.

Read the original:
NANOBIOTIX Announces Fast Track Designation Granted By U.S. FDA For Investigation of First-in-class NBTXR3 In Head and Neck Cancer - Business Wire

Multifunctional nanomedicine: Developing smarter therapeutics – Advanced Science News

Posted on by

Share

Share

Email

Althoughthe medical and pharmaceutical fields have come a long way in diagnosing diseasestates and producing highly potent drugs, the lack of effective delivery ofsuch therapeutics to the target organ with desired pharmacokinetics remains oneof the major challenges in this process.

The advent of nanotechnology, along with advances in protein engineering and materials science, have brought new hope to patients. The impact of nanotechnology on medicine nanomedicine is recognized by the development of novel nanoscale therapeutics and diagnostic and imaging modalities.

Ina recent review published in WIREs Nanomedicine and Nanobiotechnology, Professor Joerg Lahann and his team from the University of Michigan discuss state-of-the-art nanoparticle drug delivery platforms, their advantages and shortcomings, and future directions towards clinical translation.

The ability to impart multiple functions to a single delivery system, engineering both bulk and surface properties, provides a means to answer some of the greatest remaining challenges in the field of drug delivery, said Jason Gregory, a PhD student in the Lahann Lab.

In fact, approaches to address this conundruminclude the development of multifunctional particles, cell-mediated transportmechanisms, and the use of biologically derived materials. Multifunctionalparticles can possess two or more dissimilar properties through surface or bulkanisotropy.

For example, the electrohydrodynamic co-jetting process, which was pioneered in the Lahann lab, permits the creation of multicompartmental particles. Independently engineering individual compartments of the nanoparticle leads to an ability to incorporate materials with orthogonal properties that may offer a solution to simultaneously address multiple biological barriers.

Multicompartmental particles provide a set ofunique features for nanoparticle targeting and controlled release ofcombination drugs, said Dr. Joerg Lahann, the Wolfgang Pauli CollegiateProfessor of Chemical Engineering and Director of the Biointerfaces Instituteat the University of Michigan.

While traditional nanoparticles fail to efficiently deliver the drug to target sites, our bodys circulatory cells as natural carriers of many substances have evolved properties to optimally perform delivery functions. Imparting these properties into the design of the drug delivery platforms by combining nanoparticles with circulatory cells enhances the overall outcome of the system, added Nahal Habibi, a PhD student in the Lahann Lab working on cell-mediated drug delivery strategies.

Leukocytes are particularly good candidates because they can naturally migrate to disease-relevant regions that are often inaccessible by traditional nanoparticles, and have been used to carry therapeutic nanoparticles to cross the bloodbrain barrier in a Parkinsons disease model.

Synthetic protein nanoparticles are another emerging trend in nanomedicine.

Advances in designing novel multicompartmental polymer/protein nanoparticles utilizing the intersection of polymer chemistry and protein biochemistry offers promise in engineering the next generation of nanoparticle formulations, said Daniel Quevedo, another PhD candidate in Prof. Lahanns group.

Reference: Nahal Habibi et al. Emerging methods in therapeutics using multifunctional nanoparticles. WIREs Nanomedicine and Nanobiotechnology (2020). DOI: 10.1002/wnan.1625

Excerpt from:
Multifunctional nanomedicine: Developing smarter therapeutics - Advanced Science News

Biomedical Applications of Zeolitic Nanoparticles, with an Emphasis on | IJN – Dove Medical Press

Posted on by

Hossein Derakhshankhah, 1, 2,* Samira Jafari, 1, 2,* Sajad Sarvari, 3 Ebrahim Barzegari, 4 Faezeh Moakedi, 5 Milad Ghorbani, 6 Behrang Shiri Varnamkhasti, 1 Mehdi Jaymand, 7 Zhila Izadi, 1, 8 Lobat Tayebi 9

1Pharmaceutical Sciences Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran; 2Zistmavad Pharmed Co., Tehran, Iran; 3Department of Pharmaceutical and Pharmacological Science, School of Medicine, West Virginia University, Morgantown, WV, USA; 4Medical Biology Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran; 5Department of Biochemistry and Molecular Biology, School of Medicine, West Virginia University, Morgantown, WV, USA; 6Department of Chemical Engineering, College of Engineering, University of Tehran, Tehran, Iran; 7Nano Drug Delivery Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran; 8Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran; 9Marquette University School of Dentistry, Milwaukee, WI 53201, USA

*These authors contributed equally to this work

Correspondence: Zhila Izadi; Lobat Tayebi Email izadi_zh@razi.tums.ac.ir; lobat.tayebi@marquette.edu

Abstract: The advent of porous materials, in particular zeolitic nanoparticles, has opened up unprecedented putative research avenues in nanomedicine. Zeolites with intracrystal mesopores are low framework density aluminosilicates possessing a regular porous structure along with intricate channels. Their unique physiochemical as well as physiological parameters necessitate a comprehensive overview on their classifications, fabrication platforms, cellular/macromolecular interactions, and eventually their prospective biomedical applications through illustrating the challenges and opportunities in different integrative medical and pharmaceutical fields. More particularly, an update on recent advances in zeolite-accommodated drug delivery and the prevalent challenges regarding these molecular sieves is to be presented. In conclusion, strategies to accelerate the translation of these porous materials from bench to bedside along with common overlooked physiological and pharmacological factors of zeolite nanoparticles are discussed and debated. Furthermore, for zeolite nanoparticles, it is a matter of crucial importance, in terms of biosafety and nanotoxicology, to appreciate the zeolite-bio interface once the zeolite nanoparticles are exposed to the bio-macromolecules in biological media. We specifically shed light on interactions of zeolite nanoparticles with fibrinogen and amyloid beta which had been comprehensively investigated in our recent reports. Given the significance of zeolite nanoparticles interactions with serum or interstitial proteins conferring them new biological identity, the preliminary approaches for deeper understanding of administration, distribution, metabolism and excretion of zeolite nanoparticles are elucidated.

Keywords: zeolite, mesoporous, nanostructure, biosafety, biomedical applications

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

See the article here:
Biomedical Applications of Zeolitic Nanoparticles, with an Emphasis on | IJN - Dove Medical Press

Healthcare Nanotechnology (Nanomedicine) Market Share, Size, Future Demand, Global Research, Top Leading Player, Emerging Trends and Forecast to 2015 …

Posted on by

In 2018, the market size of Casing Heads Market is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2018; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.

In this report, 2018 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Casing Heads .

This report studies the global market size of Casing Heads , especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).

Request Sample Report @ https://www.researchmoz.com/enquiry.php?type=S&repid=2566962&source=atm

This study presents the Casing Heads Market production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. Casing Heads history breakdown data from 2014 to 2018, and forecast to 2025.

For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2018.

In global Casing Heads market, the following companies are covered:

TechnipFMCJMP Petroleum TechnologiesDelta CorporationGE Oil & GasIntegrated EquipmentWellhead Systems Incorporated (WSI)TIGER VALVE COMPANYHorizon WellheadWorldwide Oilfield Machine (WOM)Larkin ProductsIAL ENGINEERING SERVICES

Segment by RegionsNorth AmericaEuropeChinaJapan

Segment by TypeMonolithic TypeCombined Type

Segment by ApplicationOil/Gas WellsOther

Make An EnquiryAbout This Report @ https://www.researchmoz.com/enquiry.php?type=E&repid=2566962&source=atm

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Casing Heads product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Casing Heads , with price, sales, revenue and global market share of Casing Heads in 2017 and 2018.

Chapter 3, the Casing Heads competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Casing Heads breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2018.

Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2018.

You can Buy This Report from Here @ https://www.researchmoz.com/checkout?rep_id=2566962&licType=S&source=atm

Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2018.

Chapter 12, Casing Heads market forecast, by regions, type and application, with sales and revenue, from 2018 to 2024.

Chapter 13, 14 and 15, to describe Casing Heads sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Link:
Healthcare Nanotechnology (Nanomedicine) Market Share, Size, Future Demand, Global Research, Top Leading Player, Emerging Trends and Forecast to 2015 ...

Students of the Month: November | Local – Fredericksburg.com

Posted on by

Hannah Williams, the daughter of Donald Williams and Sandra Williams, is a senior at Brooke Point High School. Hannah has ben a member of National Honor Society, Spanish Honor Society, Inspire BP, HOSA, Model UN and Spirit Club. Hannah has been a member of the varsity gymnastics team and has received awards for Most Improved. She has been named to the honor roll every year and received academic honors and academic excellence awards. She has also been recognized by the Virginia House of Delegates. Hannah has been a junior volunteer at Stafford Hospital, and she is a certified EMT volunteer at Brooke Fire Station. She also volunteers through her church and through her membership in NHS. Hannah plans to attend a four-year university to study either nursing or biology.

Alanda Guan, the daughter of Min Gao and Xue Guan, is a senior at Colonial Forge High School. Alanda has served as co-president of Environmental Club, president of Science Honor Society and vice president of Spanish Honor Society. She has been a member of National Honor Society, Math Honor Society, Fossil Free Fredericksburg and Chamber Orchestra. She tutors a middle school student, privately. Alanda has been named an AP Scholar with Distinction and has been placed on the AB honor roll. Alanda has served her community at the Stafford Junction Brainbuilders Program, working as tutor during the school year and as a group leader during summer camp. She has also been a Mary Washington Hospital junior volunteer and helped with Friends of the Rappahannock River cleanups. Alanda plans to attend the University of Virginia and major in biology.

Carter Sprinkle is a senior at Courtland High School. Carter has served as treasurer of National Honor Society, vice president of Spanish Honor Society, and has been a member of Environmental club, which completed bulb and tree planting projects, and donated to help the school purchase filtered water fountains. She is also a senior leader with the Youth In Philanthropy program of The Community Foundation. Carter is a member of Symphonic Orchestra and received Superior rating for Assessments. She placed second for the 2-mile during Track District Championship. Carter has also served as captain of the varsity field hockey team. She was named first team All-District and All-Region, and she has received the Coachs Award for field hockey, demonstrating leadership on and off the field. She also holds the saves record at Courtland High School with 28 saves during one game.

Natalie Polanosky is a senior at Fredericksburg Christian High School. Natalie has been involved in FCS Leadership Team since her freshman year. Through this, she has had the opportunity to attend ACSIs National Leadership Conference two years in a row. She has also been the chaplin for Student Council, served as junior class vice president and senior class president. Natalie has choreographed the schools spring musical, Freaky Friday. She has been a member of the varsity swim team for four years, qualifying for VISAA states every year and holding two records for FCS. She has also been a varsity cheerleader. Natalie has coached gymnastics at Stafford Gymnastics for three years, taught acrobatics at Polaris Dance Institute and InSuRGe Dance company, and choreographed/assistant choreographed multiple shows with Christian Youth Theater. Natalie will attend college to pursue a degree in linguistics, she has taken both French and Spanish throughout the past four years and grown very passionate about language.

Emma Elizabeth Kruus, the daughter of Mikael and Marijayne Kruus, is a senior at James Monroe High School. Emma has been a member of National Honor Society and the JUMP Mentorship Program. She has served as executive treasurer of SCA. Emma is a member of DECA; she has served as secretary and vice-president. She was awarded second place for Community Service Project at DECA International Career Development Conference and second place at DECA State Leadership Conference. Emma is a Monroe Scholar. She has received the School Board Merit Award, and she has been named Outstanding Student in IB English and AP Virginia/U.S. History. Emma has played varsity lacrosse and in the JM Winter Lacrosse League. She has been named All Region, All District second team, and All Area honorable mention. Emma was 2019 Fredericksburg Area Teen Gala co-chair for St. Jude Childrens Research Hospital which raised $62,212 and 2020 Fredericksburg Area Teen Gala co-chair for St. Jude Childrens Research Hospital. She has served as teen volunteer coordinator at the Josh Hardy Superhero Celebration and volunteered at the Ceili Leahy Day of Service. Emma plans to attend a four-year university and major in pre-law.

Alex Catahan, the son of Rodolfo and Susan Catahan, is a senior at Massaponax High School. Throughout high school, Alex has been awarded AP Calculus BC award at the Commonwealth Governors School program, and he has received an award for above 4.0 GPA all four years of high school. He has also received the all-around CGS award, awarded to one student who is unanimously chosen by the teachers in the program. Alex was also nominated and selected to attend Boys State. The class he enjoyed most in high school was calculus. Alex wants to attend the University of Virginia and major in biomedical engineering. In the future, he hopes to be on the forefront of biomedical research and research nanomedicine in cancer therapeutics.

William Schmitt, son of Corinne and Daniel Schmitt of Stafford County, is a senior at Mountain View High School. William is a full IB student who tutors other students for math and chemistry. He is president of Latin Club, part of the Lacrosse team, and has been awarded the title Face of IB within the full IB program. He plans to continue his education at the college level, majoring in computer science.

Dulanda Saintcyr, the daughter of Gertrude Bonheur and Jean Saintcyr, is a senior at North Stafford High School. Dulanda is known as a compassionate and strong person, so it is no surprise that her goal is becoming a civil rights attorney. Dulanda has pushed for equality and recognition of others in a variety of ways for the North Stafford community. She is the founder in North Staffords Black History Month, president of the Stafford NAACP Youth Council for three years, treasurer of the National Honor Society, a member of the superintendents Equity, Diversity and Opportunity Committee, and cofounder and communications director of the Mobilizing Youth Project (MYP). MYP was specifically designed to increase youth involvement in local politics. Additionally, Dulandas four-year-long independent research project is on Racial Inequality on Youth Development. This process has afforded her the opportunity to publish her information in her first novel, For the Souls with Different Tones, in 2018. Dulanda has made a positive and empowering impact on North Stafford High School, where she encourages her teachers, friends and family in so many ways.

Sarah Statler, the daughter of Kristi and John Statler, is a senior at Riverbend High School. Sarah is a member of National Honor Society, Math Honor Society, Science Honor Society, Marketing Honor Society, Spanish Honor Society and Spanish Club. She is a member of SCA, serving as Bear Squad leader and as a senate council member. She has been named to distinguished honor rolls and received academic letters. She has been named Student of the Year in AP Calculus and honors math analysis. She has been named an AAU Academic All-American. As a member of DECA, Sarah has served as district president and vice president of state regions three and four. She has earned a DECA letter, is an international competition finalist, a state competition finalist, and customer service and school-based enterprise certified. She has received a merit award and been named Marketing Student of the Year. She has also served DECA as community service coordinator. Sarah has played varsity volleyball, serving as captain, and she has been libero for Fredericksburg Juniors Volleyball Club. She has been a member of the varsity swim team, receiving the award for Best Work Ethic. She is a summer swim coach and has received the summer swim coaches award. She has also been a member of the varsity tennis team. Sarah is an Ambassador Girl Scout. She serves her community as a tutor for elementary and high school students. She has also volunteered at Mary Washington Hospital, the SPCA and at Harvest Hayride. Sarah will continue her education at a four-year college or university and plans to major in kinesiology, biology or chemistry.

Melani Corral, the daughter of Dina Corral and Juan Corral, is a senior at Spotsylvania High School. Melani is president of Spanish Club, and she is a member of French Club, Future Business Leaders of America and Newspaper Club. Melani has been a member of the varsity girls soccer team and Phoenix travel soccer team, and she has served both as captain, playing defender and midfielder. She is an Ambassador Girl Scout. Melani has received three academic letters, and was recognized for three years with the highest achievement in French. Melani is a volunteer translator and intern at LUCHA Ministries Inc. She also volunteers as coach of a Latinas Soccer team of mothers. Melani is a Taekwondo Black Belt and has volunteered as an instructor assistant. Melani plans to pursue a bachelors degree in pre-law and business, and a minor in Spanish. She would like to attend law school and become an immigration lawyer.

Michaline Johnston, the daughter of Michael and Jacqueline Johnston, is a senior at Stafford High School. Michaline has been a member of National Honor Society, French Honor Society, Math Honor Society, Science Honor Society, French Club and Science Olympiad. She has also been a member of the track and cross country teams. Michaline has also served the JROTC Drill Team as commander. Michaline hopes to attend West Point or Penn State to major in either computer science or physics.

Amy Paz Cuervo, the daughter of Gustavo Paz Cuervo and Maribel Lamas, was selected as Student of the Month of October at Brooke Point High School. Amy is president of Cafe Espanol, vice president of career development in DECA and co-founder of IB Ambassadors. She has also been a member of National Honor Society, Spanish Honor Society, FBLA and Inspire BP. Amy has received academic excellence awards, and the IB Passion awards for physics and Spanish. She was awarded second place in DECA competition for restaurant and food service management. Amy tutors in Spanish, and she helps set up and clean up at school events like IB info night and Flight School. Amy plans to major in aerospace engineering at a four-year university and to pursue a masters degree.

Read more:
Students of the Month: November | Local - Fredericksburg.com

Growing Demand for Eco-friendly Products to Bolster the Growth of the Healthcare Nanotechnology (Nanomedicine) Market during 2015 2021 – Primo…

Posted on by

The comprehensive report published by Persistence Market Research offers an in-depth intelligence related to the various factors that are likely to impact the demand, revenue generation, and sales of the Healthcare Nanotechnology (Nanomedicine) Market. In addition, the report singles out the different parameters that are expected to influence the overall dynamics of the Healthcare Nanotechnology (Nanomedicine) Market during the forecast period 2015 2021.

As per the findings of the presented study, the Healthcare Nanotechnology (Nanomedicine) Market is poised to surpass the value of ~US$ XX by the end of 2029 growing at a CAGR of ~XX% over the assessment period. The report includes a thorough analysis of the upstream raw materials, supply-demand ratio of the Healthcare Nanotechnology (Nanomedicine) in different regions, import-export trends and more to provide readers a fair understanding of the global market scenario.

ThisPress Release will help you to understand the Volume, growth with Impacting Trends. Click HERE To get SAMPLE PDF (Including Full TOC, Table & Figures) athttps://www.persistencemarketresearch.co/samples/6370

The report segregates the Healthcare Nanotechnology (Nanomedicine) Market into different segments to provide a detailed understanding of the various aspects of the market. The competitive analysis of the Healthcare Nanotechnology (Nanomedicine) Market includes valuable insights based on which, market players can formulate impactful growth strategies to enhance their presence in the Healthcare Nanotechnology (Nanomedicine) Market.

Key findings of the report:

The report aims to eliminate the following doubts related to the Healthcare Nanotechnology (Nanomedicine) Market:

Get Access To TOC Covering 200+ Topics athttps://www.persistencemarketresearch.co/toc/6370

Key players in the global nanomedicine market include: Abbott Laboratories, CombiMatrix Corporation, GE Healthcare, Sigma-Tau Pharmaceuticals, Inc., Johnson & Johnson, Mallinckrodt plc, Merck & Company, Inc., Nanosphere, Inc., Pfizer, Inc., Celgene Corporation, Teva Pharmaceutical Industries Ltd., and UCB (Union chimique belge) S.A.

Key geographies evaluated in this report are:

Key features of this report

In order to get a strategic overview of the market,Access Research Methodology Prepared By Experts athttps://www.persistencemarketresearch.co/methodology/6370

Reasons to buy from PMR

About us:

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact us:

Persistence Market Research

305 Broadway, 7th Floor

New York City, NY 10007

United States

Ph.no. +1-646-568-7751

The rest is here:
Growing Demand for Eco-friendly Products to Bolster the Growth of the Healthcare Nanotechnology (Nanomedicine) Market during 2015 2021 - Primo...

Healthcare IT Market trends research and projections – GroundAlerts.com

Posted on by

The consumerization in healthcare information technology has reached a tipping point, the impact of which has been felt across healthcare IT market. The need to ensure comfort and security for patients has brought about a major transformation in the medical sphere, leading to a path-breaking intersection of IT and healthcare. The deployment of IT has equipped the healthcare industry with nanomedicine, virtual healthcare, 3D printing, robot-assisted surgery, and more. These advancements, aided by the investments by the governments worldwide, have brought about a massive change in the healthcare IT industry outlook.

The global healthcare IT market has also gained traction on account of innumerable parameters, prominent among them being, the increasing geriatric populace and the changing consumer lifestyles. Indeed, these have led to a spate of diseases worldwide, consequently surging the demand for a highly sophisticated healthcare IT network in order to lower errors in administration processes and ensure efficient medical data and patient record management.

Request sample copy of this report @ http://decresearch.com/request-sample/detail/232

Consumer expectations have also changed in the last decade or so, leading to healthcare providers focusing on prioritizing efficient management of healthcare data. This has subsequently led to the implementation of innovative technologies in the medical ecosphere, augmenting the revenue graph of the global healthcare IT market. Indeed, estimates claim that healthcare IT industry is expected to exceed $441.8 billion by the year 2025.

While numerous IT solutions are deployed in the healthcare space, one of the most significant ones is that of electronic health records. Undeniably, healthcare IT industry has gained much via rapid adoption of the EHR technology by healthcare specialists in the U.S. and other economies. According to the National Electronic Health Records Survey, 2017, approximately 9 out of 10 office-based physicians had adopted any type of EHR, while certified EHRs were adopted by 4 out of 5 office-based physicians. Since 2008, the rate of EHR adoption has more than doubled from 42 percent to nearly 86 percent in 2017. The accelerated adoption of EHR will thus drive the growth graph of healthcare IT industry from electronic health records. As a matter of fact, estimates claim that EHR-based healthcare IT market size will cross $97.8 billion by 2025.

Request for discount @ http://decresearch.com/request-discount/232

Regionally speaking, it has been forecast that the United States will crop up as a prime growth avenue for the global healthcare IT industry, primarily driven by numerous investments in medical care infrastructure and government mandates. More than half a decade ago, The U.S. Department of Health and Human Services (HHS) had mandated the adoption of information technology by healthcare providers. A substantial growth has also been recorded in terms of investments by the U.S. government in healthcare IT since 2008.

A few years ago, the U.S. government had made an investment of about $20 billion through the HITECH (Health Information Technology for Economic and Clinical Health) Act, for setting up electronic health records. Aided by numerous government initiatives and the escalating need for an efficient healthcare management system, the U.S. healthcare IT industry is estimated to record substantial revenues by 2025.

Speaking of government initiatives, yet another regional ground touted to garner extensive proceeds in healthcare IT market is the United Kingdom. In December 2018, a new collaboration had been announced between the government and the life sciences industry, backed by a government fund worth 79 million, in order to study 5 million people and develop AI-centric diagnostic tests. Back in 2014, the UK government has also announced an investment of $5.4 billion in healthcare IT for a five-year period. It comes as no surprise therefore, that the UK healthcare IT market, powered by government initiatives, will reach $24.7 billion by the year 2025.

Get In-depth table of contents @ http://decresearch.com/toc/detail/healthcare-it-market

With the increasing prevalence of diseases and the subsequently rising demand for a sophisticated medical infrastructure, healthcare IT market contenders have been working to bring forth a slew of advancements in their service portfolio. For instance, McKesson Corporation has recently collaborated with technology leader Navigating Cancer to provide an enhanced Patient Relationship Management (PRM) platform for oncologists.

IT aided healthcare has come a long way since its inception. With massive changes in the technological landscape, many more innovations have been touted to disrupt the healthcare space. Powered by huge investments and the incorporation of advanced technologies in medical care management, healthcare IT market is expected to chart out a lucrative growth map in the forthcoming years.

Table Of Content

Chapter 1. Methodology

1.1. Methodology

1.2. Market definition

1.3. Forecast parameters

1.4. Data sources

1.4.1. Secondary

1.4.1.1. Paid sources

1.4.1.2. Unpaid sources

1.4.2. Primary

Chapter 2. Executive Summary

2.1. Healthcare information technology industry 3600 synopsis, 2014 - 2025

2.1.1. Business trends

2.1.2. Solution trends

2.1.3. End-use trends

2.1.4. Regional trends

Chapter 3. Healthcare Information Technology Industry Insights

3.1. Industry segmentation

3.2. Industry landscape, 2014 - 2025

3.3. Industry impact forces

3.3.1. Growth drivers

3.3.1.1. Growing investment towards healthcare infrastructure development in Asia Pacific region

3.3.1.2. Growing adoption of artificial intelligence

3.3.1.3. High adoption of electronic health records in developed countries such as the U.S.

3.3.1.4. Favorable government initiatives

3.3.1.5. Increasing demand for cost-saving in healthcare delivery

3.3.2. Industry pitfalls & challenges

3.3.2.1. High cost associated with implementation and maintenance

3.3.2.2. Security and privacy concerns

3.4. Growth potential analysis

3.4.1. By solution

3.4.2. By end-use

3.5. Regulatory landscape

3.5.1. U.S.

3.5.2. Europe

3.5.3. China

3.6. Technology landscape

3.7. Porter's analysis

3.8. Competitive landscape, 2017

3.8.1. Strategy dashboard

3.9. PESTEL analysis

Read the original:
Healthcare IT Market trends research and projections - GroundAlerts.com

New Class of Drugs Harnesses Gold Nanocrystals to Heal and Protect the Brain – BioSpace

Posted on by

Clene Chief Executive Officer Rob Etherington. Photo courtesy of Clene.

Clene Nanomedicine is trying to set a new gold standard in neurodegenerative diseases through the development of a new class of drugs called bioenergetic nanotherapeutics that harnesses the properties of gold nanocrystals.

The gold nanocrystals are used to amplify bioenergetic reactions in patients in order to drive intracellular biological reactions. Bioenergetic nanotherapeutics are a clean break from pharmaceutical drug development that uses classical synthetic chemistry, Clene Chief Executive Officer Rob Etherington told BioSpace in an interview. Clenes lead asset is CNM-Au8, a bioenergetic nanocatalyst under development as an add-on treatment for neurodegenerative diseases like Parkinsons disease, multiple sclerosis and Amyotrophic Lateral Sclerosis (ALS). CNM-Au8 is designed to catalyze bio cellular reactions, and so far the company has seen the asset live up to its promise in clinical studies. The companys gold nanocrystals are grown in water and patients drink the asset down. Research has so far indicated that Clene and its golden asset could become a pioneer in therapeutic neurorepair and neuroprotection.

To date, CNM-Au8 has demonstrated safety in Phase I studies, remyelination and neuroprotective effects in preclinical models and is currently being assessed in a Phase II study for the treatment of chronic optic neuropathy in patients with multiple sclerosis. Additionally, CNM-Au8 is being studies in Phase II and Phase III studies for disease progression in patients with ALS. In September, Clene presented interim results from the REPAIR-MS and REPAIR-PD Phase II studies demonstrating the effects of its lead nanocatalytic therapeutic, CNM-Au8. The preliminary data demonstrate CNM-Au8-mediated modulation of key brain bioenergetic metabolites in relapsing multiple sclerosis (MS) and Parkinson's disease (PD) patients. Data from the studies indicate catalytic bioenergetic improvements across important CNS bioenergetic metabolites, including total nicotinamide adenine dinucleotide (NAD) levels, NAD+/NADH ratio, and adenosine triphosphate (ATP) levels, indicating a homeostatic effect of CNM-Au8 on brain bioenergetics, the company said.

Etherington said the data from the REPAIR-MS and REPAIR-PD studies indicate that CNM-Au8 is working mechanistically to address a foundational challenge common to many neurodegenerative diseases, which is that stressed or failing neurons need additional energy to survive and repair.

We now have insights that CNM-Au8 is driving bioenergetics within the brain, which is a foundational insight for the further development of Clene's neurorepair clinical programs, Etherington said. He added that should the data from the interim analysis pan out, it indicated that CNM-Au8 could effectively benefit millions of people across the globe suffering from multiple sclerosis and other neurodegenerative diseases.

There are multiple drugs already on the market for these neurodegenerative diseases. CNM-Au8 is not meant to replace those drugs, but to work alongside them. Etherington explained that CNM-Au8 is not designed to target a specific protein, nor it is designed to block or antagonize something, like most drugs. Rather, Clenes compound is designed to enhance the intracellular biological actions necessary to repair and reverse neuronal damage, Etherington said.

We are purposely seeking to reverse neurodegernation. We want to let the cell take care of its own housekeeping and enhance whats naturally occurring in the central nervous system, he said.

Etherington acknowledged the concept of drinking bits of gold nanocrystals may sound like something out of a Star Trek episode, but insisted the idea is sound. Gold-salt injections were historically used to treat rheumatoid arthritis decades ago, but were dropped due to health concerns. Clene had the idea to build a stable, oral nanotherapeutic, so they could see less toxicity and drive bioenergetics targets for a suite of neurodegenerative diseases, he said.

Its so out of the box that it can be a bit mind boggling. Were breaking with the traditional path and shifting the paradigm to how we think neurodegenerative disease should be treated, he said.

Not only is Clene moving forward in its clinical assessment of CNM-Au8, the company is planning to go public with a special purpose acquisition companies (SPAC) merger before the end of 2020. 2020 has been the busiest year for this kind of stock entry, with a 250% surge. As BioSpace recently reported, there have been nearly two dozen SPAC mergers in the biotech sector this year, targeting more than $3.5 billion in proceeds. When the company goes public, Etherington said Clenes management team will remain the same and the funding raised from this reverse stock merger will provide the finances that can support the companys ongoing research.

Featured Jobs on BioSpace

Excerpt from:
New Class of Drugs Harnesses Gold Nanocrystals to Heal and Protect the Brain - BioSpace